Suffern, NY, United States of America

Lawrence Ritter


Average Co-Inventor Count = 1.9

ph-index = 4

Forward Citations = 238(Granted Patents)


Location History:

  • Rockland, NY (US) (1991)
  • Suffern, NY (US) (1977 - 1994)

Company Filing History:


Years Active: 1977-1994

Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovations of Lawrence Ritter

Introduction

Lawrence Ritter is a notable inventor based in Suffern, NY (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of topical formulations. With a total of 5 patents to his name, Ritter's work has had a meaningful impact on medical treatments.

Latest Patents

Ritter's latest patents include a vehicle for the optical application of pharmaceuticals. This topical pharmaceutical formulation is particularly useful for E-type prostaglandins and in the treatment of androgenetic alopecia. Another significant patent is for a stable, cosmetically acceptable gel formulation of tetracycline antibiotics for the topical treatment of acne in humans. In this formulation, minocycline hydrochloride is the preferred antibiotic, and the pharmaceutical vehicle consists of a volatile silicone solvent combined with an emollient ester cosolvent and a polyethylene gelling agent.

Career Highlights

Lawrence Ritter is associated with the American Cyanamid Company, where he has been able to apply his innovative ideas in a practical setting. His work has contributed to advancements in pharmaceutical formulations, enhancing treatment options for various conditions.

Collaborations

Ritter has collaborated with notable colleagues such as James R. Lawter and Bruce J. Harris, further enriching his work and expanding the scope of his inventions.

Conclusion

Lawrence Ritter's contributions to pharmaceutical innovations demonstrate his commitment to improving medical treatments through his inventive spirit. His patents reflect a dedication to enhancing the quality of life for patients through effective topical formulations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…